We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novo Asks SCOTUS to Review Foreign Manufacturer Liability Wrinkles
Novo Asks SCOTUS to Review Foreign Manufacturer Liability Wrinkles
August 30, 2013
Foreign manufacturers of FDA-approved drugs should not be held liable for personal injury in U.S. courts in cases where a U.S. subsidiary is the sponsor of a drug found to be injurious, Denmark’s Novo Nordisk claims in a petition for writ of certiorari filed with the Supreme Court.